Global Cyanocobalamin Injection Sales Market Report 2021

Cyanocobalamin is a man-made form of vitamin B12 used to prevent and treat low blood levels of this vitamin. Most people get enough vitamin B12 from their diet. Vitamin B12 is important to maintain the health of your metabolism, blood cells, and nerves.

Market Analysis and Insights: Global Cyanocobalamin Injection Market
The global Cyanocobalamin Injection market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Cyanocobalamin Injection Scope and Market Size
The global Cyanocobalamin Injection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cyanocobalamin Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Vitamins
Supplements

Segment by Application
Hospitals
Clinics
Others

The Cyanocobalamin Injection market is analysed and market size information is provided by regions (countries). Segment by Application, the Cyanocobalamin Injection market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Luitpold Pharmaceuticals
Luitpold Pharmaceuticals(Daiichi Sankyo)
Endo International
Bristol-Myers Squibb
Sanofi-Aventis
Jamieson
Teva(Actavis)
Merck
Mylan
Bayer HealthCare
Pfizer
ANGELINI
Biological E
CCEPCD
Huaxin Pharmaceutical